Selected article for: "active site and admet prediction technique"
Author: Wang, Xue-Jiao; Zhang, Jun; Wang, Shu-Qing; Xu, Wei-Ren; Cheng, Xian-Chao; Wang, Run-Ling
Title: Identification of novel multitargeted PPARa/?/d pan agonists by core hopping of rosiglitazone
  • Document date: 2014_11_7
    • ID: uotug8ej_27
    Snippet: In this study, rosiglitazone was modified by core hopping strategy to produce various analogues. Using docking and ADMET prediction technique, eight novel compounds were identified as multitargeted PPARα/γ/δ pan agonists with excellent pharmacokinetic properties. Molecular dynamics simulations of the representative Cpd#1 showed that Cpd#1 bound steadily to PPARα/γ/δ active site and restricted the target movement. These compounds have not be.....
    Document: In this study, rosiglitazone was modified by core hopping strategy to produce various analogues. Using docking and ADMET prediction technique, eight novel compounds were identified as multitargeted PPARα/γ/δ pan agonists with excellent pharmacokinetic properties. Molecular dynamics simulations of the representative Cpd#1 showed that Cpd#1 bound steadily to PPARα/γ/δ active site and restricted the target movement. These compounds have not been reported in the literature and could act as novel PPARs multitargeted agonists for antidiabetic drug research.

    Search related documents:
    Co phrase search for related documents
    • active site and antidiabetic drug research: 1
    • active site and antidiabetic drug research agonist: 1
    • active site and drug research: 1, 2, 3, 4, 5, 6, 7
    • active site and dynamic simulation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • active site and δ γ PPARα pan: 1, 2
    • active site and γ δ PPARα active site: 1, 2
    • active site and novel compound: 1, 2
    • admet docking and dynamic simulation: 1
    • admet docking and δ γ PPARα pan: 1
    • antidiabetic drug research agonist and drug research: 1
    • antidiabetic drug research agonist and δ γ PPARα pan: 1
    • antidiabetic drug research agonist and γ δ PPARα active site: 1
    • antidiabetic drug research and drug research: 1, 2
    • antidiabetic drug research and δ γ PPARα pan: 1, 2
    • antidiabetic drug research and γ δ PPARα active site: 1